Chronic mitral regurgitation predicts acute heart failure and worse outcomes after endovascular treatment for large vessel occlusion stroke
- 14 July 2024
- journal article
- research article
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 17 (8) , 823-829
Abstract
Background Valvular diseases are widely recognized as important etiologies for large vessel occlusion stroke (LVO) but their impact on outcomes among patients with LVO receiving endovascular treatment (EVT) are less well delineated. Methods This study was a post hoc exploratory analysis of the RESCUE-BT trial, DEVT trial and BASILAR prospective registry. Outcome measures included the modified Rankin Scale (mRS) score at 90 days, symptomatic intracranial hemorrhage, and post-stroke early acute heart failure (EAHF). Chronic significant mitral regurgitation (csMR) was defined as a long-existing mitral regurgitation (MR) with moderate-to-severe MR grade examined by the transthoracic echocardiography. Adjusted odds ratio (aOR) and 95% confidence interval (CI) were obtained by logistic regression models. Results Among 2011 patients in these three studies, 837 individuals receiving EVT with available information for valvular status were included in this study. In all categories of chronic valvular disorders, only csMR was related to very poor outcomes (mRS 5–6, aOR 2.76 (95% CI 1.59 to 4.78), PConclusion Our study demonstrated that csMR was a mediator of heart-brain interaction associated with poor outcomes of LVO after EVT by increasing the frequency of post-stroke EAHF. Replication of these findings in a larger cohort is warranted.Keywords
Funding Information
- National Natural Science Foundation of China (82001264, 82071323)
- Chongqing Technology Innovation and Application Development Project (2022TIAD-KPX0017)
- China Postdoctor Science Foundation (2023M740444)
This publication has 28 references indexed in Scilit:
- Mortality Rate After Coronary Revascularization in Heart Failure Patients with Coronary Artery DiseaseESC Heart Failure, 2023
- Prevalence, Clinical Characteristics and Outcomes of Heart Failure Patients with or Without Isolated or Combined Mitral and Tricuspid Regurgitation: An Analysis from the ESC-HFA Heart Failure Long-Term RegistryEuropean Journal of Heart Failure, 2023
- Prevalence, Characteristics and Prognostic Impact of Aortic Valve Disease in Patients with Heart Failure and Reduced, Mildly Reduced, and Preserved Ejection Fraction: An Analysis of the ESC Heart Failure Long-Term RegistryEuropean Journal of Heart Failure, 2023
- Impact of Mitral Regurgitation in Patients with Acute Heart Failure: Insights from the RELAX-AHF-2 TrialEuropean Journal of Heart Failure, 2023
- Effect of Intravenous Tirofiban vs Placebo Before Endovascular Thrombectomy on Functional Outcomes in Large Vessel Occlusion StrokeJAMA, 2022
- Effect of mitral regurgitation on stroke risk in patients with non-rheumatic atrial fibrillationArchives of Cardiovascular Diseases, 2022
- Effect of Endovascular Treatment Alone vs Intravenous Alteplase Plus Endovascular Treatment on Functional Independence in Patients With Acute Ischemic StrokeJAMA, 2021
- Assessment of Endovascular Treatment for Acute Basilar Artery Occlusion via a Nationwide Prospective RegistryJAMA Neurology, 2020
- Impact of valvular heart disease on oral anticoagulant therapy in non-valvular atrial fibrillation: results from the RAMSES studyJournal of Thrombosis and Thrombolysis, 2016
- Risk of Heart Failure Due to a Combination of Mild Mitral Regurgitation and Impaired Distensibility of the Left Ventricle in Patients with Old Myocardial InfarctionClinical Cardiology, 2008